Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_assertion type Assertion NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_head.
- NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_assertion description "[We found that breast cancer cells expressed KLK1 and kininogens, and that stimulation of estrogen-sensitive breast cancer cells with the B1R agonist produced down-regulation of KLK10 (a protease associated with growth suppression) but up-regulation of KLK11 and KLK6 (peptidases related to increased cell proliferation and invasiveness, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_provenance.
- NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_assertion evidence source_evidence_literature NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_provenance.
- NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_assertion SIO_000772 25503118 NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_provenance.
- NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_assertion wasDerivedFrom befree-2016 NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_provenance.
- NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_assertion wasGeneratedBy ECO_0000203 NP1247825.RA9sIPwxDZWPEPjEY78ncf45N4LYGVrmAkAWogXXgQuTg130_provenance.